IP vs SGMT
International Paper (IP) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the IP and SGMT stock pages for the full models.
Not investment advice.